Does DABIGATRAN ETEXILATE Cause Myocardial infarction? 338 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 338 reports of Myocardial infarction have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.9% of all adverse event reports for DABIGATRAN ETEXILATE.
338
Reports of Myocardial infarction with DABIGATRAN ETEXILATE
0.9%
of all DABIGATRAN ETEXILATE reports
84
Deaths
190
Hospitalizations
How Dangerous Is Myocardial infarction From DABIGATRAN ETEXILATE?
Of the 338 reports, 84 (24.9%) resulted in death, 190 (56.2%) required hospitalization, and 32 (9.5%) were considered life-threatening.
Is Myocardial infarction Listed in the Official Label?
Yes, Myocardial infarction is listed as a known adverse reaction in the official FDA drug label for DABIGATRAN ETEXILATE.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Myocardial infarction?
ROSIGLITAZONE (17,018)
TESTOSTERONE (3,396)
ADALIMUMAB (3,214)
SACUBITRIL\VALSARTAN (3,120)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391)
APIXABAN (2,010)
TICAGRELOR (1,749)
LENALIDOMIDE (1,712)
ETANERCEPT (1,693)
METFORMIN\ROSIGLITAZONE (1,640)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Myocardial infarction Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB